Department of Radiology, University of California, Davis Medical Center, 4860 Y Street, Suite 3100, Sacramento, CA, 95817, USA.
School of Medicine, University of California, Davis Medical Center, 4610 X St., Sacramento, CA, 95817, USA.
Abdom Radiol (NY). 2020 Sep;45(9):2910-2915. doi: 10.1007/s00261-020-02517-3.
To compare the rates of hormonal evaluation in patients who had CT reports describing adrenal incidentalomas with and without a specific recommendation for hormonal evaluation.
We performed a retrospective review of adult outpatients without a history of cancer who had a CT report describing an incidental adrenal nodule. Radiology reports were reviewed to determine whether a standardized macro was used which gave specific recommendations for hormonal evaluation and endocrinology consultation. If no macro was used it was determined whether the report had a recommendation for hormonal evaluation and endocrinology consultation.
A standardized macro recommending hormonal evaluation and endocrinology referral was used in 45/129 (34.8%) reports that described an incidental adrenal nodule. A recommendation for hormonal evaluation was made in 5/84 (6.0%) reports without a macro. Hormonal evaluation was performed in 24/50 (48.0%) patients whose reports recommended it and in 11/79 (13.9%) patients whose reports did not (p < 0.0001). A recommendation for endocrinology referral was made in 2/84 (2.4%) reports without a macro. Patients were seen by endocrinology in 12/47 (25.5%) patients whose reports recommended an endocrinology referral evaluation and 5/82 (6.1%) patients whose reports did not (p < 0.0001). Hormonal evaluation was performed in 17/17 (100%) patients who were seen by endocrinology and 18/112 (16.1%) patients who were not (p < 0.0001). Eleven patients (8.5%) had an evaluation suggesting hyperfunctioning nodules (4 cortisol producing, 6 aldosterone producing, and 1 pheochromocytoma).
Utilizing standardized macros that make specific recommendations for hormonal evaluation in patients with adrenal incidentalomas leads to improved adherence to clinical guidelines.
比较描述有或无激素评估具体建议的肾上腺意外瘤患者的激素评估率。
我们对无癌症病史的成年门诊患者进行了回顾性研究,这些患者的 CT 报告描述了偶然发现的肾上腺结节。回顾放射学报告以确定是否使用了标准化宏,该宏提供了激素评估和内分泌会诊的具体建议。如果未使用宏,则确定报告是否有激素评估和内分泌会诊的建议。
在描述偶然肾上腺结节的 129 份报告中,有 45 份(34.8%)使用了推荐激素评估和内分泌转介的标准化宏。在没有宏的 84 份报告中,有 5 份(6.0%)建议进行激素评估。在报告建议进行激素评估的 50 名患者中,有 24 名(48.0%)进行了评估,而在报告未建议进行激素评估的 79 名患者中,有 11 名(13.9%)进行了评估(p<0.0001)。在没有宏的 84 份报告中,有 2 份(2.4%)建议内分泌会诊。在报告建议内分泌会诊评估的 47 名患者中,有 12 名(25.5%)患者接受了内分泌会诊,而在报告未建议内分泌会诊的 82 名患者中,有 5 名(6.1%)患者接受了内分泌会诊(p<0.0001)。在接受内分泌会诊的 17 名患者中,有 17 名(100%)进行了激素评估,而在未接受内分泌会诊的 112 名患者中,有 18 名(16.1%)进行了评估(p<0.0001)。有 11 名患者(8.5%)进行了评估,提示功能性结节(4 名皮质醇产生,6 名醛固酮产生,1 名嗜铬细胞瘤)。
在描述有或无激素评估具体建议的肾上腺意外瘤患者中,使用推荐激素评估的标准化宏可提高临床指南的依从性。